Consultations

We produce prescribing guidance and other medicines resources to help patients and healthcare professionals in Wales make sure that medicines are used effectively and appropriately.

Find out more in our Medicines optimisation section.

When we produce these resources, we think it's important that people who might be affected by them have a chance to tell us their views. We ask patients and carers, patient organisations, prescribers and other healthcare professionals to comment on the resources we're developing.

Input from patients is vital, because we're aiming to improve the care and treatment that you get.

We'd like your views on the resources we're currently working on, listed below. You don't need to comment on the whole document; only on parts that seem relevant to you.

Please select the document you would like to comment on from the list below, fill in our form and send it to us at: awttc@wales.nhs.uk.

All Wales wet (neovascular) age-related macular degeneration prescribing guidelines (consultation): The purpose of these guidelines is to help NHS Wales to realise the benefits of biosimilar anti-VEGFs for patients with wAMD and services by promoting treatment consistency across health boards and facilitating the planning of medicines procurement. The guidelines aim to provide a consensus on general principles for starting, pausing and stopping treatment, the choice of treatment, and treat-and-extend rules that can be applied for biosimilar anti-VEGFs across NHS Wales.